Precision Medicine Helps Identify “At-Risk Rapid Decliners” in Early-Stage Kidney Disease

Farsad Afshinnia, MD, MS and Subramaniam Pennathur, MD discover potential lipid biomarkers that may predict the progression of type 1 diabetic kidney disease.